CN104623004A - Traditional Chinese medicine composition for treating lumbar disc herniation and bulging - Google Patents

Traditional Chinese medicine composition for treating lumbar disc herniation and bulging Download PDF

Info

Publication number
CN104623004A
CN104623004A CN201510061777.3A CN201510061777A CN104623004A CN 104623004 A CN104623004 A CN 104623004A CN 201510061777 A CN201510061777 A CN 201510061777A CN 104623004 A CN104623004 A CN 104623004A
Authority
CN
China
Prior art keywords
parts
radix
chinese medicine
herba
medicine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510061777.3A
Other languages
Chinese (zh)
Inventor
张治力
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510061777.3A priority Critical patent/CN104623004A/en
Publication of CN104623004A publication Critical patent/CN104623004A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a traditional Chinese medicine composition for treating lumbar disc herniation and bulging. The traditional Chinese medicine composition comprises the following substances in parts by weight: 6-15 parts of radix clematidis, 6-15 parts of radix cyathulae, 6-15 parts of salt-fried eucommia ulmoides, 6-15 parts of radix angelicae pubescentis, 6-15 parts of notopterygium roots, 6-15 parts of angelica sinensis, 6-15 parts of safflowers, 6-15 parts of olibanum, 6-15 parts of myrrh, 6-15 parts of rhizoma corydalis processed with vinegar, 6-15 parts of paniculate swallowwort roots, 6-15 parts of pawpaw, 6-15 parts of zaocys dhumnade, 6-15 parts of manis pentadactyla, 6-15 parts of eupolyphaga sinensis, 6-15 parts of earthworms and 6-15 parts of scorpions. The traditional Chinese medicines in the composition disclosed by the invention are interacted to take a synergistic effect, and the composition is remarkable in curative effect so as to be very worthy of being powerfully popularized.

Description

A kind of Chinese medicine composition for the treatment of prolapse of lumbar intervertebral disc bulging disease
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of Chinese medicine composition for the treatment of prolapse of lumbar intervertebral disc bulging disease.
Background technology
Prolapse of lumbar intervertebral disc bulging disease is because of degeneration of intervertebral disc, Anular disruption, and a kind of syndrome that Nucleus pulposus stimulates or pressuring neural root, cauda equina nerve show is one of modal reason of lumbago and skelalgia.The domestic people of having adds up, and lumbago and skelalgia patient accounts for surgery patient's 50%, accounts for Orthopaedics Clinic patient's 70%, has a strong impact on the health of people.
Summary of the invention
The object of this invention is to provide a kind of Chinese medicine composition for the treatment of prolapse of lumbar intervertebral disc bulging disease.
In order to realize object of the present invention, the invention provides a kind of Chinese medicine composition for the treatment of prolapse of lumbar intervertebral disc bulging disease, it comprises the material of following weight portion: Radix Clematidis 6-15 part, Radix Cyathulae 6-15 part, Cortex Eucommiae (parched with salt) 6-15 part, Radix Angelicae Pubescentis 6-15 part, Rhizoma Et Radix Notopterygii 6-15 part, Radix Angelicae Sinensis 6-15 part, Flos Carthami 6-15 part, Olibanum 6-15 part, Myrrha 6-15 part, vinegar Rhizoma Corydalis 6-15 part, Radix Cynanchi Paniculati 6-15 part, Fructus Chaenomelis 6-15 part, Zaocys 6-15 part, Squama Manis 6-15 part, Eupolyphaga Seu Steleophaga 6-15 part, Pheretima 6-15 part and Scorpio 6-15 part.
Preferably, the Chinese medicine composition of described treatment prolapse of lumbar intervertebral disc bulging disease comprises the material of following weight portion: Radix Clematidis 10 parts, Radix Cyathulae 8 parts, Cortex Eucommiae (parched with salt) 10 parts, Radix Angelicae Pubescentis 7 parts, Rhizoma Et Radix Notopterygii 8 parts, Radix Angelicae Sinensis 12 parts, 12 parts, Flos Carthami, Olibanum 10 parts, Myrrha 10 parts, vinegar Rhizoma Corydalis 8 parts, Radix Cynanchi Paniculati 9 parts, Fructus Chaenomelis 10 parts, Zaocys 7 parts, Squama Manis 7 parts, Eupolyphaga Seu Steleophaga 7 parts, Pheretima 7 parts and Scorpio 6 parts.
Preferably, the Chinese medicine composition of described treatment prolapse of lumbar intervertebral disc bulging disease also comprises the material of following weight portion: Herba Kylligac coloratae 15 parts, Herba Piperris Tonkinensis 9 parts, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 8 parts, Herba Digitariae 11 parts, well limit grass 8 parts, Radix Semiaquilegiae 10 parts, Semen Cajani 11 parts, Fructus Manglietiae fordianae 10 parts, Galla Chinensis 15 parts, Herba Orostachyos 12 parts, Folium seu Radix Rubi Ichangensis 8 parts, Flos Rosae Chinensis 9 parts, wind and cold grass 7 parts and Herba Asparagi Setacei 9 parts.
Preferably, described Chinese medicine composition can be tablet, dispersible tablet, capsule, pill or medicated wine.
The present invention also provides the purposes of compositions in the Chinese medicine of preparation treatment prolapse of lumbar intervertebral disc bulging disease, and described compositions comprises the material of following weight portion: Radix Clematidis 6-15 part, Radix Cyathulae 6-15 part, Cortex Eucommiae (parched with salt) 6-15 part, Radix Angelicae Pubescentis 6-15 part, Rhizoma Et Radix Notopterygii 6-15 part, Radix Angelicae Sinensis 6-15 part, Flos Carthami 6-15 part, Olibanum 6-15 part, Myrrha 6-15 part, vinegar Rhizoma Corydalis 6-15 part, Radix Cynanchi Paniculati 6-15 part, Fructus Chaenomelis 6-15 part, Zaocys 6-15 part, Squama Manis 6-15 part, Eupolyphaga Seu Steleophaga 6-15 part, Pheretima 6-15 part and Scorpio 6-15 part.
Preferably, described compositions comprises the material of following weight portion: Radix Clematidis 10 parts, Radix Cyathulae 8 parts, Cortex Eucommiae (parched with salt) 10 parts, Radix Angelicae Pubescentis 7 parts, Rhizoma Et Radix Notopterygii 8 parts, Radix Angelicae Sinensis 12 parts, 12 parts, Flos Carthami, Olibanum 10 parts, Myrrha 10 parts, vinegar Rhizoma Corydalis 8 parts, Radix Cynanchi Paniculati 9 parts, Fructus Chaenomelis 10 parts, Zaocys 7 parts, Squama Manis 7 parts, Eupolyphaga Seu Steleophaga 7 parts, Pheretima 7 parts and Scorpio 6 parts.
Preferably, described compositions also comprises the material of following weight portion: Herba Kylligac coloratae 15 parts, Herba Piperris Tonkinensis 9 parts, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 8 parts, Herba Digitariae 11 parts, well limit grass 8 parts, Radix Semiaquilegiae 10 parts, Semen Cajani 11 parts, Fructus Manglietiae fordianae 10 parts, Galla Chinensis 15 parts, Herba Orostachyos 12 parts, Folium seu Radix Rubi Ichangensis 8 parts, Flos Rosae Chinensis 9 parts, wind and cold grass 7 parts and Herba Asparagi Setacei 9 parts.
Preferably, described Chinese medicine can be tablet, dispersible tablet, capsule, pill or medicated wine.
Chinese medicine composition of the present invention interacts, and synergism is evident in efficacy, highly widelys popularize.
Detailed description of the invention
The present invention is further illustrated below by embodiment.It should be understood that embodiments of the invention are for illustration of the present invention instead of limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modifications that the present invention carries out.Unless otherwise stated, the percent in the present invention is percetage by weight.
Embodiment 1 medicated wine of the present invention
Take Radix Clematidis 10 grams, Radix Cyathulae 8 grams, Cortex Eucommiae (parched with salt) 10 grams, Radix Angelicae Pubescentis 7 grams, Rhizoma Et Radix Notopterygii 8 grams, Radix Angelicae Sinensis 12 grams, 12 grams, Flos Carthami, Olibanum 10 grams, Myrrha 10 grams, vinegar Rhizoma Corydalis 8 grams, Radix Cynanchi Paniculati 9 grams, Fructus Chaenomelis 10 grams, Zaocys 7 grams, Squama Manis 7 grams, Eupolyphaga Seu Steleophaga 7 grams, Pheretima 7 grams and Scorpio 6 grams, add dehydrated alcohol 2000 milliliters, at room temperature seal dipping 3 days, filter, filtrate is described medicated wine.
Embodiment 2 medicated wine of the present invention
Take Radix Clematidis 10 grams, Radix Cyathulae 8 grams, Cortex Eucommiae (parched with salt) 10 grams, Radix Angelicae Pubescentis 7 grams, Rhizoma Et Radix Notopterygii 8 grams, Radix Angelicae Sinensis 12 grams, 12 grams, Flos Carthami, Olibanum 10 grams, Myrrha 10 grams, vinegar Rhizoma Corydalis 8 grams, Radix Cynanchi Paniculati 9 grams, Fructus Chaenomelis 10 grams, Zaocys 7 grams, Squama Manis 7 grams, Eupolyphaga Seu Steleophaga 7 grams, Pheretima 7 grams, Scorpio 6 grams, Herba Kylligac coloratae 15 grams, Herba Piperris Tonkinensis 9 grams, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 8 grams, Herba Digitariae 11 grams, well limit grass 8 grams, Radix Semiaquilegiae 10 grams, Semen Cajani 11 grams, Fructus Manglietiae fordianae 10 grams, Galla Chinensis 15 grams, Herba Orostachyos 12 grams, Folium seu Radix Rubi Ichangensis 8 grams, Flos Rosae Chinensis 9 grams, wind and cold grass 7 grams and Herba Asparagi Setacei 9 grams, add dehydrated alcohol 2000 milliliters, at room temperature seal dipping 3 days, filter, filtrate is described medicated wine.
Experimental example
Diagnostic criteria
With reference to " Chinese medical disease Standardization of diagnosis and curative effect ": 1. there is waist chronic injury history; 2. lumbago companion sciatica; 3. Lumbar scoliosis deformity, physiology lordosis disappears, limitation of activity, and spinous process is other to be had tenderness and be radiated to lower limb; 4. straight-leg raising test and the reinforcement test positive, neck sign, Queckenstedt's test, the femoral nerve stretching test positive; 5. neurologic check shows that knee joint key, Achilles tendon reflex are abnormal, skin of lower extremity nerve segment areal area hyperesthesia or blunt, big toe dorsiflexion or open up Qu Li and weaken; 6. the visible narrowing of intervertebral space of x-ray plain film, vertebra edge hypertrophy, lumbar lateral bending, lordosis disappears, and gets rid of other diseases, and there is impression defect in the visible dura mater front of myelography; 7. CT scan, MRI point out intervertebral disk hernia.
Inclusive criteria
1. above-mentioned Diagnosis of Lumber Disc Prolapse standard is met;
2. without art therapy indication, the patient of suitable expectant treatment;
3. the age is between 20 ~ 65 years old, male or female.
Exclusion standard
1. age < 18 years old or > 70 years old, gestation or women breast-feeding their children, irritated or have serious gastropathy to Chinese medicine; 2. the serious organic disease such as Liver and kidney, cardiovascular and cerebrovascular vessel and hemopoietic system and psychosis is merged; 3. purulent disease, acute syndrom of cauda equina etc. around spinal tuberculosis, tumor of spine, spondylitis and myelitis, spinal column is merged; 4. other treatment is accepted the same period; 5. severe symptoms, has a strong impact on work, life, previously through system expectant treatment nonresponder; 6. with extensive Muscle paralysis, feel to go down, have and cut paralyzed patient wholly or in part; 7. there is serious intermittence postscript row, merge the narrow person of obvious Taper Pipe; 8. merge Degenerative spondylolisthesis, isthmus does not connect person.
According to above-mentioned standard, select 100 routine patients, wherein man 50 example, female 50 example, age 25-61 year, average 47 years old.Be two groups by patient, be respectively treatment group 1 and treatment group 2, often group has 50 routine patients.Two groups of Genders, age, symptom there are no significant difference, have comparability (P > 0.05).
Treatment group 1 uses the medicated wine of preparation in embodiment 1 to treat, every day twice, and each gauze that uses dips 50 grams of medicated wine even wiping intervertebral disk hernia places, continuously treatment 1 month.
Treatment group 2 uses the medicated wine of preparation in embodiment 2 to treat, every day twice, and each gauze that uses dips 50 grams of medicated wine even wiping intervertebral disk hernia places, continuously treatment 1 month.
Criterion of therapeutical effect
Formulate with reference to State Administration of Traditional Chinese Medicine " Chinese medical disease Standardization of diagnosis and curative effect " (1994).
1. cure: lumbago and skelalgia disappears, leg raising straight more than 70 degree, normal work can be recovered;
2. take a turn for the better: lumbago and skelalgia alleviates, waist movable function improves;
3. do not heal: symptom, sign are without improvement.
Statistical method
Utilize SPSS 13.0 software to process and analyze to experimental data, measurement data is with mean ± standard deviation represent, adopt t inspection, enumeration data adopts χ 2inspection, P < 0.05 represents that difference has statistical significance.
Result
Through treatment, for treatment group 1, cure 21 examples, take a turn for the better 22 examples, more 7 examples, and total effective rate is 86%, for treatment group 2, cures 32 examples, and take a turn for the better 18 examples, and total effective rate is 100%.Two groups of total effective rate comparing differences have statistical significance (P < 0.05).
Untoward reaction and toxic and side effects supervision
By detect patient blood pressure, pulse, whether there is Nausea and vomiting, dizzy clinical symptoms judges untoward reaction.Find that the systolic pressure of all patients is between 90-140mmHg, diastolic pressure is between 60-90mmHg, and pulse is 60-100 beat/min, and blood pressure and pulse all within normal range, and does not occur Nausea and vomiting, dizzy clinical symptoms.This illustrates that pharmaceutical composition of the present invention does not have obvious untoward reaction, and then proves that medicine does not have obvious toxic and side effects for human body.

Claims (8)

1. treat the Chinese medicine composition of prolapse of lumbar intervertebral disc bulging disease for one kind, it is characterized in that, it comprises the material of following weight portion: Radix Clematidis 6-15 part, Radix Cyathulae 6-15 part, Cortex Eucommiae (parched with salt) 6-15 part, Radix Angelicae Pubescentis 6-15 part, Rhizoma Et Radix Notopterygii 6-15 part, Radix Angelicae Sinensis 6-15 part, Flos Carthami 6-15 part, Olibanum 6-15 part, Myrrha 6-15 part, vinegar Rhizoma Corydalis 6-15 part, Radix Cynanchi Paniculati 6-15 part, Fructus Chaenomelis 6-15 part, Zaocys 6-15 part, Squama Manis 6-15 part, Eupolyphaga Seu Steleophaga 6-15 part, Pheretima 6-15 part and Scorpio 6-15 part.
2. the Chinese medicine composition for the treatment of prolapse of lumbar intervertebral disc bulging disease according to claim 1, it is characterized in that, it comprises the material of following weight portion: Radix Clematidis 10 parts, Radix Cyathulae 8 parts, Cortex Eucommiae (parched with salt) 10 parts, Radix Angelicae Pubescentis 7 parts, Rhizoma Et Radix Notopterygii 8 parts, Radix Angelicae Sinensis 12 parts, 12 parts, Flos Carthami, Olibanum 10 parts, Myrrha 10 parts, vinegar Rhizoma Corydalis 8 parts, Radix Cynanchi Paniculati 9 parts, Fructus Chaenomelis 10 parts, Zaocys 7 parts, Squama Manis 7 parts, Eupolyphaga Seu Steleophaga 7 parts, Pheretima 7 parts and Scorpio 6 parts.
3. the Chinese medicine composition for the treatment of prolapse of lumbar intervertebral disc bulging disease according to claim 1 and 2, it is characterized in that, it also comprises the material of following weight portion: Herba Kylligac coloratae 15 parts, Herba Piperris Tonkinensis 9 parts, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 8 parts, Herba Digitariae 11 parts, well limit grass 8 parts, Radix Semiaquilegiae 10 parts, Semen Cajani 11 parts, Fructus Manglietiae fordianae 10 parts, Galla Chinensis 15 parts, Herba Orostachyos 12 parts, Folium seu Radix Rubi Ichangensis 8 parts, Flos Rosae Chinensis 9 parts, wind and cold grass 7 parts and Herba Asparagi Setacei 9 parts.
4. the Chinese medicine composition for the treatment of prolapse of lumbar intervertebral disc bulging disease according to claim 3, it is characterized in that, described Chinese medicine composition can be tablet, dispersible tablet, capsule, pill or medicated wine.
5. the purposes of compositions in the Chinese medicine of preparation treatment prolapse of lumbar intervertebral disc bulging disease, it is characterized in that, described compositions comprises the material of following weight portion: Radix Clematidis 6-15 part, Radix Cyathulae 6-15 part, Cortex Eucommiae (parched with salt) 6-15 part, Radix Angelicae Pubescentis 6-15 part, Rhizoma Et Radix Notopterygii 6-15 part, Radix Angelicae Sinensis 6-15 part, Flos Carthami 6-15 part, Olibanum 6-15 part, Myrrha 6-15 part, vinegar Rhizoma Corydalis 6-15 part, Radix Cynanchi Paniculati 6-15 part, Fructus Chaenomelis 6-15 part, Zaocys 6-15 part, Squama Manis 6-15 part, Eupolyphaga Seu Steleophaga 6-15 part, Pheretima 6-15 part and Scorpio 6-15 part.
6. purposes according to claim 5, it is characterized in that, described compositions comprises the material of following weight portion: Radix Clematidis 10 parts, Radix Cyathulae 8 parts, Cortex Eucommiae (parched with salt) 10 parts, Radix Angelicae Pubescentis 7 parts, Rhizoma Et Radix Notopterygii 8 parts, Radix Angelicae Sinensis 12 parts, 12 parts, Flos Carthami, Olibanum 10 parts, Myrrha 10 parts, vinegar Rhizoma Corydalis 8 parts, Radix Cynanchi Paniculati 9 parts, Fructus Chaenomelis 10 parts, Zaocys 7 parts, Squama Manis 7 parts, Eupolyphaga Seu Steleophaga 7 parts, Pheretima 7 parts and Scorpio 6 parts.
7. the purposes according to claim 5 or 6, it is characterized in that, described compositions also comprises the material of following weight portion: Herba Kylligac coloratae 15 parts, Herba Piperris Tonkinensis 9 parts, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 8 parts, Herba Digitariae 11 parts, well limit grass 8 parts, Radix Semiaquilegiae 10 parts, Semen Cajani 11 parts, Fructus Manglietiae fordianae 10 parts, Galla Chinensis 15 parts, Herba Orostachyos 12 parts, Folium seu Radix Rubi Ichangensis 8 parts, Flos Rosae Chinensis 9 parts, wind and cold grass 7 parts and Herba Asparagi Setacei 9 parts.
8. purposes according to claim 7, is characterized in that, described Chinese medicine can be tablet, dispersible tablet, capsule, pill or medicated wine.
CN201510061777.3A 2015-02-05 2015-02-05 Traditional Chinese medicine composition for treating lumbar disc herniation and bulging Pending CN104623004A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510061777.3A CN104623004A (en) 2015-02-05 2015-02-05 Traditional Chinese medicine composition for treating lumbar disc herniation and bulging

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510061777.3A CN104623004A (en) 2015-02-05 2015-02-05 Traditional Chinese medicine composition for treating lumbar disc herniation and bulging

Publications (1)

Publication Number Publication Date
CN104623004A true CN104623004A (en) 2015-05-20

Family

ID=53202566

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510061777.3A Pending CN104623004A (en) 2015-02-05 2015-02-05 Traditional Chinese medicine composition for treating lumbar disc herniation and bulging

Country Status (1)

Country Link
CN (1) CN104623004A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105833171A (en) * 2016-04-01 2016-08-10 申连英 Traditional Chinese medicinal ointment for treating lumbar disc herniation
CN108815327A (en) * 2018-09-18 2018-11-16 朱志合 The externally applied ointment and preparation method thereof for treating rheumatic waist-leg pain prolapse of lumbar intervertebral disc osteoproliferation
CN109820944A (en) * 2019-02-10 2019-05-31 张玉琳 A kind of physical therapy medicated wine composition and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1237427A (en) * 1998-06-02 1999-12-08 张起来 Adhesive plaster for curing prolapse of lumbar intervertebral disk
CN1268368A (en) * 1999-03-25 2000-10-04 赵金田 Chinese herb medicine preparation for curing prolapse of lumbar intervertebral disk
KR100683420B1 (en) * 2002-08-23 2007-02-20 김성철 Composition for treating lumbar intervertebral disc herniation comprising a centipede

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1237427A (en) * 1998-06-02 1999-12-08 张起来 Adhesive plaster for curing prolapse of lumbar intervertebral disk
CN1268368A (en) * 1999-03-25 2000-10-04 赵金田 Chinese herb medicine preparation for curing prolapse of lumbar intervertebral disk
KR100683420B1 (en) * 2002-08-23 2007-02-20 김성철 Composition for treating lumbar intervertebral disc herniation comprising a centipede

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
刘鹏等: "《丰隆穴》", 31 January 2012 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105833171A (en) * 2016-04-01 2016-08-10 申连英 Traditional Chinese medicinal ointment for treating lumbar disc herniation
CN108815327A (en) * 2018-09-18 2018-11-16 朱志合 The externally applied ointment and preparation method thereof for treating rheumatic waist-leg pain prolapse of lumbar intervertebral disc osteoproliferation
CN109820944A (en) * 2019-02-10 2019-05-31 张玉琳 A kind of physical therapy medicated wine composition and preparation method thereof

Similar Documents

Publication Publication Date Title
CN100546616C (en) A kind of Chinese medicine for the treatment of osteopathia
CN105055804A (en) Traditional Chinese medicine composition for treating lumbar disc herniation
CN103893463A (en) Traditional Chinese medicine composition for treating lumbar disc herniation and preparation method thereof
CN101129973A (en) Traditional Chinese medicine for treating cervical vertebra disease
CN105770734A (en) Traditional Chinese medicine composition for treating joint sore symptoms of osteoarthritis through external use
CN104758659A (en) Traditional Chinese medicine paste for treating muscle and bone diseases
CN104623004A (en) Traditional Chinese medicine composition for treating lumbar disc herniation and bulging
CN102441145B (en) Medicament for treating lumbar disc herniation and cervical spondylosis
CN103520432A (en) Traditional Chinese medicine for treating qi-stagnation and blood stasis lumbar disc herniation and preparation method thereof
CN101912536B (en) Medicinal composition for treating rheumatism and rheumatoid disease
CN1235630C (en) Chinese medicine paste for curing osteoarthropathy and preparing method
CN103550380A (en) Traditional Chinese medicine composition for treating hyperostosis
CN103463261B (en) Traditional Chinese medicine preparation for treating lumbar intervertebral disc herniation
CN104667124A (en) Traditional Chinese medicine composition capable of treating traumatic injuries and promoting factures to heal quickly
CN104784398B (en) The external-applied ointment and preparation method thereof for treating apoplexy sequelae
CN104107288A (en) Sinew-relaxing collateral-activating pill
CN102743463B (en) Bonesetting decoction promoting bone healing
CN103784604A (en) Traditional Chinese medicine composition for treating protrusion of lumbar intervertebral disc, and preparation process and application thereof
CN105687944A (en) Traditional Chinese medicine composition for treating cervical spondylosis and lumbar spondylosis
CN101007117A (en) Application of &#39;Gu Kang&#39; medicine in preparation of formulations for treating osteoarthritis and osteoporosis
CN104306536A (en) A plaster for treating nerve-root type cervical spondylosis and a preparing method thereof
CN102283942A (en) Orally-administrated Chinese medicinal preparation for treating ankylosing spondlitis
CN102178758A (en) Medicament for treating peripheral nerve of diabetes
CN115177690B (en) Traditional Chinese medicine composition for treating osteoarthritis and preparation method thereof
CN102784360B (en) Traditional Chinese medicine composition for treating lumbar disc herniation and lumbar spine bone hyperplasia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20150520

WD01 Invention patent application deemed withdrawn after publication